BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37010541)

  • 1. Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma.
    Endo Y; Moazzam Z; Woldesenbet S; Araujo Lima H; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    World J Surg; 2023 Jul; 47(7):1792-1800. PubMed ID: 37010541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis.
    Munir MM; Endo Y; Lima HA; Alaimo L; Moazzam Z; Shaikh C; Poultsides GA; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    J Gastrointest Surg; 2023 Mar; 27(3):544-554. PubMed ID: 36652178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
    Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
    Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
    J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1392-1403. PubMed ID: 36383331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
    Alaimo L; Moazzam Z; Brown ZJ; Endo Y; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1340-1349. PubMed ID: 36029379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
    Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
    BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
    Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
    J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Toyoda J; Sahara K; Maithel SK; Abbott DE; Poultsides GA; Wolfgang C; Fields RC; He J; Scoggins C; Idrees K; Shen P; Endo I; Pawlik TM
    Ann Surg Oncol; 2022 Nov; 29(12):7605-7614. PubMed ID: 35768667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Pawlik TM
    Ann Surg Oncol; 2023 Apr; 30(4):1966-1977. PubMed ID: 36622527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
    Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
    World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
    Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
    Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.
    Miyata T; Yamashita YI; Yamao T; Umezaki N; Tsukamoto M; Kitano Y; Yamamura K; Arima K; Kaida T; Nakagawa S; Imai K; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Int J Clin Oncol; 2017 Jun; 22(3):526-532. PubMed ID: 28205002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
    Kawashima J; Sahara K; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Cauchy F; Koerkamp BG; Matsuyama R; Endo I; Pawlik TM
    J Gastrointest Surg; 2024 Jan; 28(1):18-25. PubMed ID: 38353070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
    Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
    Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study.
    Chen C; Su J; Wu H; Qiu Y; Song T; Mao X; He Y; Cheng Z; Zhai W; Li J; Geng Z; Tang Z
    Eur J Surg Oncol; 2023 Apr; 49(4):780-787. PubMed ID: 36404249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W; Jeong CY; Jang JY; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Ryu JH; Yang K; Choi CS; Park YH; Nah YW; Kim R; Navarro J; Han DH; Choi GH; Kang CM; Kim KS; Hong SC
    Eur J Surg Oncol; 2020 May; 46(5):832-838. PubMed ID: 31806519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.